Insulin-like growth factors and their binding proteins in human colonocytes: preferential degradation of insulin-like growth factor binding protein 2 in colonic cancers
1997

Insulin-like Growth Factors and Their Binding Proteins in Human Colon Cancer

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): NP Michell, MJS Langman, MC Eggo

Primary Institution: University of Birmingham

Hypothesis

The study aims to determine the role of the IGF axis in colonic cancer.

Conclusion

The study concludes that IGFBPs are synthesized and secreted by colonic mucosa cells, but proteolysis of IGFBP-2 occurs in colon cancer tissue, potentially providing a growth advantage to cancer cells.

Supporting Evidence

  • All normal and cancer tissues expressed IGF-I mRNA.
  • IGFBP-2 mRNA was expressed in all normal and cancer samples.
  • Cancer cells showed increased incorporation of [35S]methionine and [3H]thymidine when treated with IGF-I.

Takeaway

This study looked at how certain proteins related to growth factors behave in normal and cancerous colon cells, finding that cancer cells break down a specific protein that helps control growth.

Methodology

The study compared the expression of IGFs and IGFBPs in paired samples of normal and tumor colonic tissue using Northern and Western blotting, and assessed cellular growth responses to IGF-I.

Limitations

The study did not quantify the levels of mRNA expression, which may affect the interpretation of the results.

Participant Demographics

All cancers were sporadic with Duke's stage B or C classification.

Statistical Information

P-Value

p<0.02

Statistical Significance

p<0.02

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication